Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Alzheimer Disease | 46 | 2023 | 8717 | 1.470 |
Why?
|
Stress Disorders, Post-Traumatic | 13 | 2024 | 4628 | 1.070 |
Why?
|
Arthritis, Rheumatoid | 24 | 2015 | 3788 | 0.960 |
Why?
|
Neurofibrillary Tangles | 9 | 2023 | 457 | 0.860 |
Why?
|
Plaque, Amyloid | 11 | 2023 | 769 | 0.750 |
Why?
|
Capacity Building | 1 | 2022 | 266 | 0.660 |
Why?
|
E2F Transcription Factors | 1 | 2018 | 270 | 0.590 |
Why?
|
Receptor-Like Protein Tyrosine Phosphatases, Class 2 | 1 | 2017 | 21 | 0.570 |
Why?
|
Peptides, Cyclic | 8 | 2013 | 390 | 0.560 |
Why?
|
tau Proteins | 16 | 2023 | 2107 | 0.540 |
Why?
|
Polymorphism, Single Nucleotide | 26 | 2019 | 16044 | 0.530 |
Why?
|
Dementia | 6 | 2022 | 2741 | 0.500 |
Why?
|
Cognition Disorders | 9 | 2021 | 3967 | 0.490 |
Why?
|
Genetic Predisposition to Disease | 27 | 2019 | 18075 | 0.460 |
Why?
|
Autoantibodies | 9 | 2022 | 2115 | 0.450 |
Why?
|
Receptors, Complement 3b | 2 | 2011 | 136 | 0.450 |
Why?
|
Cognition | 12 | 2024 | 7057 | 0.440 |
Why?
|
DNA Methylation | 10 | 2024 | 4427 | 0.440 |
Why?
|
Prefrontal Cortex | 4 | 2018 | 2224 | 0.440 |
Why?
|
Amyloid beta-Peptides | 16 | 2023 | 3887 | 0.440 |
Why?
|
Epigenesis, Genetic | 6 | 2024 | 3824 | 0.420 |
Why?
|
Aging | 12 | 2024 | 8731 | 0.390 |
Why?
|
Tourette Syndrome | 2 | 2025 | 400 | 0.370 |
Why?
|
Estradiol | 1 | 2018 | 1947 | 0.360 |
Why?
|
Apolipoproteins E | 8 | 2020 | 1459 | 0.320 |
Why?
|
Female | 113 | 2025 | 396520 | 0.310 |
Why?
|
Cohort Studies | 36 | 2024 | 41710 | 0.310 |
Why?
|
Multiple Sclerosis | 7 | 2021 | 3229 | 0.300 |
Why?
|
Genome-Wide Association Study | 26 | 2021 | 12806 | 0.300 |
Why?
|
HLA Antigens | 1 | 2013 | 1339 | 0.290 |
Why?
|
Nurses | 5 | 2022 | 2503 | 0.290 |
Why?
|
Apolipoprotein E4 | 4 | 2018 | 709 | 0.280 |
Why?
|
Humans | 145 | 2025 | 766766 | 0.270 |
Why?
|
Genetics, Population | 2 | 2022 | 943 | 0.270 |
Why?
|
Genomics | 2 | 2022 | 5923 | 0.270 |
Why?
|
Aged, 80 and over | 40 | 2021 | 59550 | 0.270 |
Why?
|
Lupus Nephritis | 1 | 2010 | 324 | 0.260 |
Why?
|
Intracranial Hemorrhages | 3 | 2022 | 810 | 0.260 |
Why?
|
Circadian Rhythm | 4 | 2022 | 2593 | 0.250 |
Why?
|
Insurance Claim Review | 1 | 2010 | 744 | 0.250 |
Why?
|
Middle Aged | 70 | 2024 | 223257 | 0.240 |
Why?
|
Stroke | 4 | 2022 | 9741 | 0.240 |
Why?
|
Age of Onset | 4 | 2025 | 3342 | 0.240 |
Why?
|
Brain | 16 | 2023 | 27159 | 0.240 |
Why?
|
Genotype | 21 | 2020 | 13036 | 0.230 |
Why?
|
Genetic Association Studies | 9 | 2018 | 2746 | 0.230 |
Why?
|
Prospective Studies | 24 | 2024 | 54871 | 0.230 |
Why?
|
Lupus Erythematosus, Systemic | 4 | 2010 | 2160 | 0.230 |
Why?
|
Aged | 61 | 2024 | 171343 | 0.230 |
Why?
|
Tic Disorders | 1 | 2025 | 140 | 0.220 |
Why?
|
Case-Control Studies | 18 | 2024 | 22248 | 0.220 |
Why?
|
Male | 83 | 2025 | 364142 | 0.220 |
Why?
|
Sex Characteristics | 4 | 2025 | 2645 | 0.210 |
Why?
|
Longitudinal Studies | 14 | 2024 | 14762 | 0.200 |
Why?
|
CpG Islands | 5 | 2018 | 1208 | 0.200 |
Why?
|
Nephrogenic Fibrosing Dermopathy | 2 | 2014 | 42 | 0.200 |
Why?
|
Hormone Replacement Therapy | 2 | 2020 | 751 | 0.200 |
Why?
|
Neurites | 2 | 2022 | 389 | 0.190 |
Why?
|
Adult | 53 | 2025 | 223307 | 0.190 |
Why?
|
Genetic Variation | 5 | 2022 | 6612 | 0.190 |
Why?
|
Amyotrophic Lateral Sclerosis | 2 | 2023 | 1481 | 0.190 |
Why?
|
Haplotypes | 5 | 2020 | 2727 | 0.190 |
Why?
|
TDP-43 Proteinopathies | 2 | 2018 | 40 | 0.190 |
Why?
|
Autopsy | 4 | 2018 | 1011 | 0.180 |
Why?
|
Adaptor Proteins, Signal Transducing | 4 | 2015 | 2902 | 0.180 |
Why?
|
Sexual Harassment | 1 | 2022 | 82 | 0.180 |
Why?
|
Depression | 7 | 2024 | 8228 | 0.180 |
Why?
|
Risk Factors | 33 | 2024 | 74881 | 0.180 |
Why?
|
Algorithms | 5 | 2021 | 14072 | 0.170 |
Why?
|
Receptors, Immunologic | 3 | 2015 | 1418 | 0.170 |
Why?
|
C-Reactive Protein | 6 | 2022 | 3853 | 0.170 |
Why?
|
Optic Neuritis | 1 | 2022 | 173 | 0.170 |
Why?
|
Chromosomes, Human, X | 1 | 2021 | 319 | 0.160 |
Why?
|
Psychopathology | 1 | 2022 | 434 | 0.160 |
Why?
|
Amyloid Precursor Protein Secretases | 2 | 2021 | 616 | 0.160 |
Why?
|
Alleles | 8 | 2020 | 6895 | 0.160 |
Why?
|
ROC Curve | 3 | 2013 | 3620 | 0.160 |
Why?
|
Hippocampus | 3 | 2018 | 3776 | 0.160 |
Why?
|
Demyelinating Diseases | 1 | 2021 | 354 | 0.160 |
Why?
|
Fluorescence Resonance Energy Transfer | 1 | 2021 | 415 | 0.160 |
Why?
|
Schizophrenia | 3 | 2024 | 6976 | 0.150 |
Why?
|
Neuromyelitis Optica | 1 | 2022 | 266 | 0.150 |
Why?
|
Remission Induction | 1 | 2024 | 2413 | 0.150 |
Why?
|
LDL-Receptor Related Proteins | 2 | 2017 | 118 | 0.150 |
Why?
|
Tumor Suppressor Proteins | 4 | 2019 | 2801 | 0.150 |
Why?
|
Conversion Disorder | 1 | 2021 | 201 | 0.150 |
Why?
|
Sex Offenses | 1 | 2022 | 355 | 0.140 |
Why?
|
Claudins | 1 | 2018 | 116 | 0.140 |
Why?
|
Nuclear Proteins | 4 | 2017 | 5795 | 0.140 |
Why?
|
Craniocerebral Trauma | 1 | 2021 | 493 | 0.140 |
Why?
|
Substrate Specificity | 1 | 2021 | 1750 | 0.140 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 2 | 2024 | 3724 | 0.140 |
Why?
|
Memory Disorders | 2 | 2014 | 1193 | 0.140 |
Why?
|
Databases, Factual | 3 | 2018 | 8066 | 0.140 |
Why?
|
Serpins | 1 | 2018 | 245 | 0.130 |
Why?
|
Research Design | 3 | 2024 | 6207 | 0.130 |
Why?
|
Peptide Fragments | 4 | 2018 | 5143 | 0.130 |
Why?
|
Brain Ischemia | 2 | 2020 | 3001 | 0.130 |
Why?
|
Endarterectomy, Carotid | 1 | 2022 | 556 | 0.130 |
Why?
|
Dystonic Disorders | 1 | 2021 | 354 | 0.130 |
Why?
|
Ischemic Attack, Transient | 1 | 2022 | 874 | 0.130 |
Why?
|
Oxidative Phosphorylation | 1 | 2018 | 502 | 0.130 |
Why?
|
Football | 1 | 2022 | 504 | 0.130 |
Why?
|
Amyloid | 3 | 2015 | 849 | 0.130 |
Why?
|
Polymorphism, Genetic | 5 | 2013 | 4249 | 0.130 |
Why?
|
Psychometrics | 2 | 2024 | 3060 | 0.130 |
Why?
|
Membrane Glycoproteins | 3 | 2015 | 3702 | 0.130 |
Why?
|
Educational Status | 4 | 2024 | 2510 | 0.130 |
Why?
|
Phenotype | 11 | 2020 | 16724 | 0.120 |
Why?
|
Smoking | 5 | 2020 | 9077 | 0.120 |
Why?
|
Muscle Proteins | 2 | 2018 | 1160 | 0.120 |
Why?
|
Immunoglobulin J Recombination Signal Sequence-Binding Protein | 1 | 2015 | 133 | 0.120 |
Why?
|
Menopause | 3 | 2023 | 1657 | 0.120 |
Why?
|
Epistasis, Genetic | 1 | 2017 | 353 | 0.120 |
Why?
|
Depressive Disorder, Major | 2 | 2024 | 4810 | 0.120 |
Why?
|
Carotid Stenosis | 1 | 2022 | 858 | 0.120 |
Why?
|
Ankyrins | 1 | 2014 | 123 | 0.110 |
Why?
|
Monomeric Clathrin Assembly Proteins | 2 | 2012 | 24 | 0.110 |
Why?
|
Odds Ratio | 5 | 2013 | 9661 | 0.110 |
Why?
|
Young Adult | 16 | 2025 | 59939 | 0.110 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 2 | 2022 | 347 | 0.110 |
Why?
|
Environment | 3 | 2015 | 1120 | 0.110 |
Why?
|
Africa, Southern | 2 | 2024 | 60 | 0.110 |
Why?
|
Reproduction | 1 | 2018 | 645 | 0.110 |
Why?
|
RNA, Untranslated | 1 | 2017 | 455 | 0.110 |
Why?
|
Metabolic Networks and Pathways | 1 | 2018 | 800 | 0.110 |
Why?
|
Interleukin-6 | 3 | 2022 | 3227 | 0.110 |
Why?
|
Antiporters | 1 | 2015 | 275 | 0.110 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2015 | 414 | 0.110 |
Why?
|
Hypophosphatemia | 1 | 2014 | 92 | 0.110 |
Why?
|
Neocortex | 1 | 2017 | 414 | 0.110 |
Why?
|
Resilience, Psychological | 1 | 2021 | 808 | 0.110 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2016 | 4410 | 0.110 |
Why?
|
Tauopathies | 1 | 2017 | 325 | 0.110 |
Why?
|
Health Surveys | 2 | 2021 | 4055 | 0.110 |
Why?
|
Immunologic Factors | 2 | 2017 | 1594 | 0.100 |
Why?
|
Biological Products | 1 | 2022 | 948 | 0.100 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2017 | 606 | 0.100 |
Why?
|
Age Factors | 7 | 2021 | 18397 | 0.100 |
Why?
|
Alcohol Drinking | 3 | 2013 | 4045 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2018 | 996 | 0.100 |
Why?
|
Membrane Transport Proteins | 2 | 2017 | 1029 | 0.100 |
Why?
|
Neurons | 5 | 2022 | 9515 | 0.100 |
Why?
|
DNA Mutational Analysis | 1 | 2021 | 4114 | 0.100 |
Why?
|
Verbal Learning | 1 | 2014 | 459 | 0.100 |
Why?
|
Immunologic Surveillance | 1 | 2012 | 92 | 0.100 |
Why?
|
Incidence | 7 | 2020 | 21525 | 0.100 |
Why?
|
Period Circadian Proteins | 1 | 2012 | 97 | 0.100 |
Why?
|
Area Under Curve | 2 | 2013 | 1638 | 0.100 |
Why?
|
Family Health | 1 | 2017 | 1254 | 0.100 |
Why?
|
Homeodomain Proteins | 2 | 2019 | 2430 | 0.100 |
Why?
|
Microfilament Proteins | 1 | 2017 | 1129 | 0.100 |
Why?
|
Time Perception | 1 | 2012 | 87 | 0.100 |
Why?
|
Proportional Hazards Models | 5 | 2020 | 12534 | 0.100 |
Why?
|
Disease Susceptibility | 1 | 2018 | 1791 | 0.090 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2015 | 566 | 0.090 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 1 | 2017 | 551 | 0.090 |
Why?
|
Neuropeptides | 1 | 2017 | 950 | 0.090 |
Why?
|
South Africa | 3 | 2024 | 1875 | 0.090 |
Why?
|
Receptors, Complement | 1 | 2012 | 254 | 0.090 |
Why?
|
Adolescent | 15 | 2025 | 88904 | 0.090 |
Why?
|
Autistic Disorder | 1 | 2021 | 1238 | 0.090 |
Why?
|
Delirium | 1 | 2023 | 1698 | 0.090 |
Why?
|
Chi-Square Distribution | 2 | 2017 | 3432 | 0.090 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2016 | 4652 | 0.090 |
Why?
|
Phosphoenolpyruvate Carboxykinase (GTP) | 1 | 2010 | 40 | 0.090 |
Why?
|
Seasons | 1 | 2017 | 1521 | 0.090 |
Why?
|
Cholesterol Ester Transfer Proteins | 1 | 2011 | 113 | 0.090 |
Why?
|
HLA-DR Antigens | 2 | 2010 | 609 | 0.090 |
Why?
|
Cross-Sectional Studies | 9 | 2024 | 26310 | 0.090 |
Why?
|
Rheumatic Fever | 1 | 2011 | 73 | 0.090 |
Why?
|
Hand Joints | 1 | 2011 | 58 | 0.090 |
Why?
|
Poverty | 1 | 2022 | 2714 | 0.090 |
Why?
|
Chromosomes, Human, Pair 12 | 1 | 2012 | 432 | 0.090 |
Why?
|
Disease Progression | 8 | 2023 | 13640 | 0.090 |
Why?
|
Brain Concussion | 1 | 2022 | 1431 | 0.090 |
Why?
|
Fatty Acids | 1 | 2018 | 1806 | 0.090 |
Why?
|
Models, Immunological | 1 | 2012 | 517 | 0.090 |
Why?
|
Temporal Lobe | 1 | 2018 | 1716 | 0.090 |
Why?
|
Sweden | 1 | 2013 | 1382 | 0.090 |
Why?
|
Body Weight | 1 | 2021 | 4626 | 0.080 |
Why?
|
Clusterin | 1 | 2010 | 72 | 0.080 |
Why?
|
Parity | 1 | 2013 | 931 | 0.080 |
Why?
|
Brain Injuries | 1 | 2022 | 2053 | 0.080 |
Why?
|
Estrogen Replacement Therapy | 1 | 2016 | 1205 | 0.080 |
Why?
|
Ethiopia | 2 | 2024 | 485 | 0.080 |
Why?
|
Lipid Metabolism | 1 | 2018 | 1895 | 0.080 |
Why?
|
HIV Antibodies | 1 | 2016 | 1337 | 0.080 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2021 | 1882 | 0.080 |
Why?
|
Postmenopause | 2 | 2016 | 2517 | 0.080 |
Why?
|
Presenilin-1 | 1 | 2013 | 665 | 0.080 |
Why?
|
Antibodies, Anti-Idiotypic | 1 | 2010 | 347 | 0.080 |
Why?
|
Biomedical Research | 1 | 2025 | 3459 | 0.080 |
Why?
|
Clinical Trials as Topic | 2 | 2023 | 8045 | 0.080 |
Why?
|
Kenya | 2 | 2024 | 759 | 0.080 |
Why?
|
DNA Repair | 1 | 2018 | 2050 | 0.080 |
Why?
|
Metacarpal Bones | 1 | 2009 | 77 | 0.080 |
Why?
|
Mothers | 1 | 2019 | 2208 | 0.080 |
Why?
|
Cell Adhesion Molecules | 1 | 2015 | 1612 | 0.080 |
Why?
|
Extracellular Matrix Proteins | 1 | 2013 | 833 | 0.080 |
Why?
|
Genome, Human | 3 | 2021 | 4443 | 0.080 |
Why?
|
Glutathione Transferase | 1 | 2010 | 565 | 0.080 |
Why?
|
Health | 1 | 2011 | 397 | 0.080 |
Why?
|
Parkinson Disease | 1 | 2022 | 2884 | 0.080 |
Why?
|
Stress, Psychological | 2 | 2024 | 4527 | 0.080 |
Why?
|
Models, Statistical | 3 | 2025 | 5091 | 0.070 |
Why?
|
Genetic Loci | 3 | 2012 | 2630 | 0.070 |
Why?
|
Heme Oxygenase-1 | 1 | 2010 | 364 | 0.070 |
Why?
|
Rheumatoid Factor | 4 | 2011 | 185 | 0.070 |
Why?
|
Medical Records | 2 | 2012 | 1408 | 0.070 |
Why?
|
Body Mass Index | 2 | 2024 | 13050 | 0.070 |
Why?
|
Intracellular Signaling Peptides and Proteins | 3 | 2014 | 2885 | 0.070 |
Why?
|
Receptors, Cell Surface | 1 | 2017 | 2815 | 0.070 |
Why?
|
Hypertension | 3 | 2024 | 8616 | 0.070 |
Why?
|
Contrast Media | 3 | 2014 | 5329 | 0.070 |
Why?
|
Severity of Illness Index | 5 | 2025 | 15908 | 0.070 |
Why?
|
Arthroplasty, Replacement, Knee | 2 | 2010 | 1389 | 0.070 |
Why?
|
Selection, Genetic | 1 | 2012 | 878 | 0.070 |
Why?
|
Brachial Artery | 1 | 2009 | 373 | 0.070 |
Why?
|
Gadolinium | 2 | 2014 | 964 | 0.070 |
Why?
|
Population Surveillance | 1 | 2017 | 2594 | 0.070 |
Why?
|
Uganda | 2 | 2024 | 1353 | 0.070 |
Why?
|
Diet | 3 | 2024 | 8088 | 0.070 |
Why?
|
Borrelia burgdorferi | 1 | 2008 | 183 | 0.070 |
Why?
|
Mental Health | 1 | 2021 | 3270 | 0.070 |
Why?
|
Monocytes | 2 | 2013 | 2600 | 0.070 |
Why?
|
Antibodies, Neutralizing | 1 | 2016 | 2010 | 0.070 |
Why?
|
Lewy Bodies | 2 | 2018 | 140 | 0.070 |
Why?
|
United States | 9 | 2024 | 72951 | 0.070 |
Why?
|
Nervous System Diseases | 1 | 2017 | 1659 | 0.070 |
Why?
|
Executive Function | 1 | 2015 | 1396 | 0.070 |
Why?
|
Ovarian Neoplasms | 1 | 2023 | 4904 | 0.070 |
Why?
|
Logistic Models | 4 | 2018 | 13278 | 0.070 |
Why?
|
Gadolinium DTPA | 1 | 2009 | 823 | 0.070 |
Why?
|
Arthritis, Psoriatic | 1 | 2009 | 219 | 0.060 |
Why?
|
Herpesvirus 4, Human | 1 | 2011 | 1080 | 0.060 |
Why?
|
Risk | 5 | 2020 | 9602 | 0.060 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2022 | 4349 | 0.060 |
Why?
|
Sex Factors | 4 | 2025 | 10619 | 0.060 |
Why?
|
Silicon Dioxide | 1 | 2006 | 217 | 0.060 |
Why?
|
Solvents | 1 | 2006 | 299 | 0.060 |
Why?
|
Regional Blood Flow | 1 | 2009 | 1478 | 0.060 |
Why?
|
Hand | 1 | 2011 | 909 | 0.060 |
Why?
|
Time Factors | 8 | 2023 | 40149 | 0.060 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2011 | 617 | 0.060 |
Why?
|
Pravastatin | 1 | 2007 | 391 | 0.060 |
Why?
|
Inflammation | 4 | 2022 | 10860 | 0.060 |
Why?
|
Analysis of Variance | 2 | 2011 | 6214 | 0.060 |
Why?
|
Netherlands | 2 | 2020 | 2277 | 0.060 |
Why?
|
Africa, Eastern | 1 | 2024 | 76 | 0.060 |
Why?
|
Vasodilation | 1 | 2009 | 969 | 0.060 |
Why?
|
Electronic Health Records | 2 | 2013 | 4880 | 0.060 |
Why?
|
Proteomics | 3 | 2023 | 3914 | 0.060 |
Why?
|
Drosophila melanogaster | 1 | 2013 | 1725 | 0.060 |
Why?
|
Nerve Tissue Proteins | 1 | 2017 | 4400 | 0.060 |
Why?
|
Membrane Proteins | 2 | 2021 | 7868 | 0.060 |
Why?
|
Drosophila Proteins | 1 | 2013 | 1704 | 0.060 |
Why?
|
Child | 9 | 2025 | 80668 | 0.060 |
Why?
|
Blood Pressure | 1 | 2019 | 8533 | 0.060 |
Why?
|
Hospitals, University | 1 | 2005 | 572 | 0.060 |
Why?
|
Microglia | 3 | 2021 | 1370 | 0.050 |
Why?
|
Gene Frequency | 4 | 2012 | 3624 | 0.050 |
Why?
|
Asialoglycoprotein Receptor | 1 | 2023 | 36 | 0.050 |
Why?
|
Arthritis | 1 | 2009 | 684 | 0.050 |
Why?
|
Transcription Factors | 3 | 2018 | 12150 | 0.050 |
Why?
|
Drosophila | 1 | 2011 | 1508 | 0.050 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2010 | 1721 | 0.050 |
Why?
|
Cerebral Cortex | 2 | 2020 | 5753 | 0.050 |
Why?
|
Europe | 2 | 2020 | 3430 | 0.050 |
Why?
|
G(M2) Ganglioside | 1 | 2022 | 14 | 0.050 |
Why?
|
Genetic Structures | 1 | 2022 | 12 | 0.050 |
Why?
|
Quality of Life | 3 | 2022 | 13476 | 0.050 |
Why?
|
Genome | 1 | 2011 | 1752 | 0.050 |
Why?
|
Lyme Disease | 1 | 2008 | 627 | 0.050 |
Why?
|
Health Services Research | 1 | 2010 | 1811 | 0.050 |
Why?
|
Motor Activity | 1 | 2012 | 2711 | 0.050 |
Why?
|
Introns | 2 | 2015 | 966 | 0.050 |
Why?
|
Risk Assessment | 5 | 2021 | 24295 | 0.050 |
Why?
|
Range of Motion, Articular | 1 | 2008 | 1597 | 0.050 |
Why?
|
Gangliosides | 1 | 2022 | 132 | 0.050 |
Why?
|
Emigrants and Immigrants | 1 | 2008 | 550 | 0.050 |
Why?
|
Androgens | 1 | 2009 | 1280 | 0.050 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2019 | 12245 | 0.050 |
Why?
|
Caffeine | 1 | 2006 | 702 | 0.050 |
Why?
|
Factor Analysis, Statistical | 1 | 2024 | 1001 | 0.050 |
Why?
|
Bipolar Disorder | 1 | 2019 | 5130 | 0.050 |
Why?
|
Retrospective Studies | 10 | 2023 | 81635 | 0.050 |
Why?
|
Patient Compliance | 1 | 2012 | 2694 | 0.050 |
Why?
|
Reproducibility of Results | 3 | 2024 | 20144 | 0.050 |
Why?
|
Aquaporin 4 | 1 | 2022 | 161 | 0.050 |
Why?
|
Cartilage, Articular | 1 | 2008 | 1104 | 0.050 |
Why?
|
Carrier Proteins | 1 | 2014 | 4924 | 0.050 |
Why?
|
Probability | 2 | 2020 | 2476 | 0.050 |
Why?
|
Pain | 2 | 2022 | 5098 | 0.050 |
Why?
|
Presenilins | 1 | 2021 | 51 | 0.050 |
Why?
|
Lung | 1 | 2019 | 10067 | 0.040 |
Why?
|
Transcription, Genetic | 1 | 2014 | 7609 | 0.040 |
Why?
|
Linkage Disequilibrium | 2 | 2017 | 1996 | 0.040 |
Why?
|
Antirheumatic Agents | 2 | 2009 | 1383 | 0.040 |
Why?
|
Rheumatic Diseases | 1 | 2007 | 658 | 0.040 |
Why?
|
Follow-Up Studies | 7 | 2019 | 39309 | 0.040 |
Why?
|
Fibrosis | 1 | 2007 | 2077 | 0.040 |
Why?
|
Predictive Value of Tests | 4 | 2009 | 15416 | 0.040 |
Why?
|
Linear Models | 3 | 2016 | 5874 | 0.040 |
Why?
|
Interleukin-8 | 1 | 2023 | 702 | 0.040 |
Why?
|
Hypercholesterolemia | 1 | 2007 | 1145 | 0.040 |
Why?
|
Knee Joint | 1 | 2008 | 1682 | 0.040 |
Why?
|
Aniline Compounds | 2 | 2017 | 1079 | 0.040 |
Why?
|
Disability Evaluation | 2 | 2017 | 1827 | 0.040 |
Why?
|
Methotrexate | 1 | 2006 | 1719 | 0.040 |
Why?
|
Aspartic Acid Endopeptidases | 1 | 2021 | 308 | 0.040 |
Why?
|
Cricetulus | 1 | 2021 | 810 | 0.040 |
Why?
|
Arthroplasty, Replacement, Hip | 1 | 2010 | 1417 | 0.040 |
Why?
|
Gynecologic Surgical Procedures | 1 | 2022 | 287 | 0.040 |
Why?
|
Hormones | 1 | 2023 | 866 | 0.040 |
Why?
|
Skin Diseases | 1 | 2007 | 1084 | 0.040 |
Why?
|
Endpoint Determination | 1 | 2022 | 592 | 0.040 |
Why?
|
Child, Preschool | 4 | 2025 | 42577 | 0.040 |
Why?
|
Prognosis | 5 | 2021 | 29948 | 0.040 |
Why?
|
Patient Education as Topic | 1 | 2009 | 2334 | 0.040 |
Why?
|
Amyloidosis | 2 | 2018 | 877 | 0.040 |
Why?
|
Memory | 2 | 2020 | 2192 | 0.040 |
Why?
|
Africa | 1 | 2021 | 726 | 0.040 |
Why?
|
Urban Population | 1 | 2006 | 2040 | 0.040 |
Why?
|
AIDS Vaccines | 2 | 2016 | 898 | 0.040 |
Why?
|
CHO Cells | 1 | 2021 | 1376 | 0.040 |
Why?
|
Occupational Diseases | 1 | 2006 | 1456 | 0.040 |
Why?
|
HIV Infections | 2 | 2016 | 17536 | 0.040 |
Why?
|
Receptor, Melatonin, MT2 | 1 | 2019 | 83 | 0.040 |
Why?
|
Osteoarthritis, Knee | 1 | 2008 | 1251 | 0.040 |
Why?
|
Erythrocytes | 1 | 2007 | 2412 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2023 | 1733 | 0.040 |
Why?
|
Sequence Analysis, RNA | 2 | 2017 | 2039 | 0.040 |
Why?
|
Sclerosis | 1 | 2018 | 211 | 0.040 |
Why?
|
Multivariate Analysis | 4 | 2015 | 12064 | 0.040 |
Why?
|
Computer Simulation | 3 | 2018 | 6259 | 0.040 |
Why?
|
Single-Blind Method | 2 | 2013 | 1587 | 0.040 |
Why?
|
Central Nervous System Stimulants | 1 | 2006 | 1168 | 0.040 |
Why?
|
Fibrinolytic Agents | 2 | 2022 | 2078 | 0.040 |
Why?
|
Cricetinae | 1 | 2021 | 2416 | 0.040 |
Why?
|
Family Characteristics | 1 | 2022 | 1002 | 0.040 |
Why?
|
Models, Biological | 1 | 2013 | 9461 | 0.040 |
Why?
|
Anxiety | 2 | 2023 | 4670 | 0.030 |
Why?
|
Steroids | 1 | 2022 | 936 | 0.030 |
Why?
|
Health Behavior | 1 | 2008 | 2649 | 0.030 |
Why?
|
Mutation | 3 | 2018 | 30213 | 0.030 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2011 | 8926 | 0.030 |
Why?
|
Blood Sedimentation | 2 | 2008 | 234 | 0.030 |
Why?
|
CLOCK Proteins | 1 | 2017 | 89 | 0.030 |
Why?
|
Endothelium, Vascular | 1 | 2009 | 4424 | 0.030 |
Why?
|
Opioid-Related Disorders | 1 | 2012 | 2188 | 0.030 |
Why?
|
Bone Density | 1 | 2009 | 3491 | 0.030 |
Why?
|
Genetic Heterogeneity | 1 | 2020 | 735 | 0.030 |
Why?
|
Residence Characteristics | 2 | 2018 | 2116 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2009 | 14652 | 0.030 |
Why?
|
Kidney Diseases | 1 | 2007 | 2101 | 0.030 |
Why?
|
Amyloidogenic Proteins | 1 | 2017 | 151 | 0.030 |
Why?
|
Health Promotion | 1 | 2008 | 2209 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 5 | 2021 | 36567 | 0.030 |
Why?
|
Chronic Disease | 2 | 2022 | 9357 | 0.030 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2010 | 3250 | 0.030 |
Why?
|
Phosphorylation | 2 | 2020 | 8307 | 0.030 |
Why?
|
Pregnancy | 2 | 2019 | 30237 | 0.030 |
Why?
|
Fatigue | 1 | 2023 | 1555 | 0.030 |
Why?
|
Leukoencephalopathy, Progressive Multifocal | 1 | 2017 | 133 | 0.030 |
Why?
|
Blood Pressure Determination | 1 | 2019 | 646 | 0.030 |
Why?
|
Ethylene Glycols | 1 | 2017 | 196 | 0.030 |
Why?
|
Amyloid beta-Protein Precursor | 1 | 2021 | 1117 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2018 | 635 | 0.030 |
Why?
|
Analgesics, Opioid | 1 | 2012 | 3837 | 0.030 |
Why?
|
Repressor Proteins | 2 | 2019 | 2978 | 0.030 |
Why?
|
HIV-1 | 1 | 2012 | 6948 | 0.030 |
Why?
|
Sex Distribution | 1 | 2020 | 2274 | 0.030 |
Why?
|
Epidemiologic Methods | 2 | 2010 | 1326 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2023 | 2354 | 0.030 |
Why?
|
Homozygote | 1 | 2020 | 1775 | 0.030 |
Why?
|
Causality | 1 | 2021 | 1252 | 0.030 |
Why?
|
Multigene Family | 1 | 2018 | 1081 | 0.030 |
Why?
|
Respiratory Function Tests | 1 | 2019 | 1691 | 0.030 |
Why?
|
Gene Expression Regulation | 3 | 2018 | 11920 | 0.030 |
Why?
|
Age Distribution | 1 | 2020 | 2869 | 0.030 |
Why?
|
Proteins | 2 | 2022 | 6002 | 0.030 |
Why?
|
Transcription Initiation Site | 1 | 2014 | 190 | 0.030 |
Why?
|
Treatment Outcome | 5 | 2022 | 65273 | 0.030 |
Why?
|
Sulfotransferases | 1 | 2014 | 150 | 0.030 |
Why?
|
Radiography | 3 | 2011 | 6968 | 0.030 |
Why?
|
Positron-Emission Tomography | 2 | 2023 | 6550 | 0.030 |
Why?
|
Income | 1 | 2022 | 1875 | 0.030 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2008 | 4056 | 0.030 |
Why?
|
Viremia | 1 | 2016 | 727 | 0.030 |
Why?
|
Anisotropy | 1 | 2017 | 1285 | 0.030 |
Why?
|
HLA-D Antigens | 1 | 2013 | 130 | 0.030 |
Why?
|
Markov Chains | 1 | 2017 | 974 | 0.030 |
Why?
|
Animals | 7 | 2022 | 168930 | 0.030 |
Why?
|
Endophenotypes | 1 | 2015 | 258 | 0.030 |
Why?
|
Gene Expression | 2 | 2015 | 7585 | 0.030 |
Why?
|
Psychiatry | 1 | 2025 | 1715 | 0.030 |
Why?
|
China | 1 | 2019 | 2383 | 0.030 |
Why?
|
Receptor, EphA1 | 1 | 2012 | 20 | 0.030 |
Why?
|
Cyclic Nucleotide Phosphodiesterases, Type 7 | 1 | 2011 | 6 | 0.020 |
Why?
|
Cholesterol, HDL | 1 | 2019 | 1812 | 0.020 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2004 | 2184 | 0.020 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2013 | 322 | 0.020 |
Why?
|
Biometry | 1 | 2015 | 571 | 0.020 |
Why?
|
Quantitative Trait Loci | 2 | 2011 | 2136 | 0.020 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2013 | 370 | 0.020 |
Why?
|
Proteoglycans | 1 | 2014 | 806 | 0.020 |
Why?
|
Models, Genetic | 2 | 2012 | 3450 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2009 | 10745 | 0.020 |
Why?
|
Dextrans | 1 | 2013 | 574 | 0.020 |
Why?
|
Survivors | 1 | 2022 | 2379 | 0.020 |
Why?
|
Neuropsychological Tests | 2 | 2015 | 7119 | 0.020 |
Why?
|
Receptors, Notch | 1 | 2015 | 751 | 0.020 |
Why?
|
Epstein-Barr Virus Nuclear Antigens | 1 | 2011 | 158 | 0.020 |
Why?
|
Neural Stem Cells | 1 | 2018 | 895 | 0.020 |
Why?
|
Neurofibrils | 1 | 2010 | 75 | 0.020 |
Why?
|
Glucose Transporter Type 1 | 1 | 2011 | 186 | 0.020 |
Why?
|
CD4 Lymphocyte Count | 1 | 2016 | 2586 | 0.020 |
Why?
|
Coronary Artery Disease | 1 | 2010 | 6558 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2018 | 2142 | 0.020 |
Why?
|
Arthrography | 1 | 2011 | 149 | 0.020 |
Why?
|
Cerebral Infarction | 1 | 2015 | 968 | 0.020 |
Why?
|
Astrocytes | 1 | 2018 | 1351 | 0.020 |
Why?
|
Cost of Illness | 1 | 2020 | 1949 | 0.020 |
Why?
|
Cause of Death | 1 | 2020 | 3716 | 0.020 |
Why?
|
Parents | 1 | 2024 | 3593 | 0.020 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2022 | 2763 | 0.020 |
Why?
|
Infant | 2 | 2024 | 36461 | 0.020 |
Why?
|
Leukocytes, Mononuclear | 1 | 2016 | 1852 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2018 | 2448 | 0.020 |
Why?
|
HLA-B Antigens | 1 | 2010 | 330 | 0.020 |
Why?
|
Serine | 1 | 2013 | 828 | 0.020 |
Why?
|
Cytokines | 2 | 2015 | 7438 | 0.020 |
Why?
|
Receptors, IgG | 1 | 2012 | 562 | 0.020 |
Why?
|
Massachusetts | 3 | 2008 | 8891 | 0.020 |
Why?
|
Psychotic Disorders | 1 | 2024 | 3276 | 0.020 |
Why?
|
Radionuclide Imaging | 1 | 2013 | 1986 | 0.020 |
Why?
|
Integrins | 1 | 2013 | 839 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2013 | 1604 | 0.020 |
Why?
|
Protein Isoforms | 1 | 2013 | 1716 | 0.020 |
Why?
|
Immunologic Memory | 1 | 2015 | 1377 | 0.020 |
Why?
|
Social Marketing | 1 | 2008 | 51 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2005 | 9244 | 0.020 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2019 | 6020 | 0.020 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2015 | 1139 | 0.020 |
Why?
|
Animals, Genetically Modified | 1 | 2013 | 1562 | 0.020 |
Why?
|
Alternative Splicing | 1 | 2013 | 1103 | 0.020 |
Why?
|
Mortality | 1 | 2020 | 2910 | 0.020 |
Why?
|
Actigraphy | 1 | 2012 | 526 | 0.020 |
Why?
|
Binding Sites | 1 | 2017 | 6012 | 0.020 |
Why?
|
Postoperative Complications | 3 | 2023 | 15831 | 0.020 |
Why?
|
Exons | 1 | 2013 | 2392 | 0.020 |
Why?
|
Exercise | 1 | 2024 | 5945 | 0.020 |
Why?
|
Viral Load | 1 | 2016 | 3385 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2017 | 10384 | 0.020 |
Why?
|
Prevalence | 1 | 2024 | 15835 | 0.020 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 1 | 2007 | 64 | 0.020 |
Why?
|
Survival Analysis | 1 | 2020 | 10100 | 0.020 |
Why?
|
RNA | 1 | 2017 | 2715 | 0.020 |
Why?
|
Tuberous Sclerosis | 1 | 2015 | 1039 | 0.020 |
Why?
|
Acculturation | 1 | 2008 | 179 | 0.020 |
Why?
|
Meta-Analysis as Topic | 1 | 2012 | 1365 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2013 | 3757 | 0.020 |
Why?
|
Decision Support Techniques | 1 | 2017 | 2006 | 0.020 |
Why?
|
Sleep | 1 | 2022 | 4815 | 0.020 |
Why?
|
Heterozygote | 1 | 2013 | 2795 | 0.020 |
Why?
|
Manometry | 1 | 2009 | 458 | 0.020 |
Why?
|
Cytoskeletal Proteins | 1 | 2012 | 1325 | 0.020 |
Why?
|
Rats | 1 | 2022 | 23717 | 0.020 |
Why?
|
Anticoagulants | 1 | 2022 | 4855 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2012 | 2846 | 0.020 |
Why?
|
Genetic Markers | 1 | 2012 | 2603 | 0.020 |
Why?
|
Thiazoles | 1 | 2013 | 1529 | 0.020 |
Why?
|
Mitochondrial Proteins | 1 | 2011 | 980 | 0.020 |
Why?
|
Pain Threshold | 1 | 2009 | 606 | 0.020 |
Why?
|
Atrophy | 1 | 2010 | 1631 | 0.020 |
Why?
|
Regression Analysis | 1 | 2014 | 6329 | 0.020 |
Why?
|
Mood Disorders | 1 | 2012 | 1127 | 0.020 |
Why?
|
Kinetics | 1 | 2012 | 6287 | 0.020 |
Why?
|
RNA Interference | 1 | 2013 | 2827 | 0.010 |
Why?
|
Fibromyalgia | 1 | 2009 | 407 | 0.010 |
Why?
|
Family | 1 | 2015 | 3209 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2012 | 21162 | 0.010 |
Why?
|
Culture | 1 | 2008 | 622 | 0.010 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2010 | 1241 | 0.010 |
Why?
|
Antigens, Differentiation | 1 | 2007 | 921 | 0.010 |
Why?
|
Prosthesis-Related Infections | 1 | 2010 | 497 | 0.010 |
Why?
|
Brazil | 1 | 2008 | 1249 | 0.010 |
Why?
|
Serum Albumin | 1 | 2007 | 675 | 0.010 |
Why?
|
Chromatin | 1 | 2016 | 2977 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2024 | 26389 | 0.010 |
Why?
|
Absorptiometry, Photon | 1 | 2009 | 1707 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2017 | 4047 | 0.010 |
Why?
|
Trans-Activators | 1 | 2013 | 2855 | 0.010 |
Why?
|
Epitopes | 1 | 2010 | 2526 | 0.010 |
Why?
|
Hip Joint | 1 | 2009 | 1017 | 0.010 |
Why?
|
Drug Synergism | 1 | 2007 | 1756 | 0.010 |
Why?
|
Heparin | 1 | 2010 | 1636 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2008 | 2921 | 0.010 |
Why?
|
Receptors, Androgen | 1 | 2009 | 1089 | 0.010 |
Why?
|
Early Diagnosis | 1 | 2008 | 1186 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2013 | 4780 | 0.010 |
Why?
|
Minority Groups | 1 | 2010 | 1208 | 0.010 |
Why?
|
Models, Neurological | 1 | 2010 | 1747 | 0.010 |
Why?
|
Treatment Refusal | 1 | 2005 | 433 | 0.010 |
Why?
|
Drug Prescriptions | 1 | 2012 | 1663 | 0.010 |
Why?
|
Perception | 1 | 2008 | 1204 | 0.010 |
Why?
|
Health Education | 1 | 2008 | 1060 | 0.010 |
Why?
|
Creatinine | 1 | 2007 | 1917 | 0.010 |
Why?
|
Drug Interactions | 1 | 2006 | 1419 | 0.010 |
Why?
|
Renal Insufficiency | 1 | 2007 | 811 | 0.010 |
Why?
|
Pain Measurement | 1 | 2012 | 3576 | 0.010 |
Why?
|
Syndrome | 1 | 2007 | 3271 | 0.010 |
Why?
|
Pandemics | 1 | 2021 | 8735 | 0.010 |
Why?
|
Autoimmunity | 1 | 2009 | 1358 | 0.010 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2013 | 3666 | 0.010 |
Why?
|
Social Class | 1 | 2010 | 2007 | 0.010 |
Why?
|
Program Evaluation | 1 | 2009 | 2504 | 0.010 |
Why?
|
Lumbar Vertebrae | 1 | 2009 | 1878 | 0.010 |
Why?
|
Genetic Testing | 1 | 2013 | 3591 | 0.010 |
Why?
|
Signal Transduction | 2 | 2015 | 23619 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2012 | 3561 | 0.010 |
Why?
|
Antibodies, Viral | 1 | 2011 | 3212 | 0.010 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2014 | 2306 | 0.010 |
Why?
|
Drug Utilization | 1 | 2005 | 1187 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2014 | 12791 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2010 | 5789 | 0.010 |
Why?
|
Data Collection | 1 | 2008 | 3321 | 0.010 |
Why?
|
Disease Outbreaks | 1 | 2008 | 1761 | 0.010 |
Why?
|
Aspirin | 1 | 2010 | 3135 | 0.010 |
Why?
|
Stents | 1 | 2010 | 3193 | 0.010 |
Why?
|
Brain Mapping | 1 | 2013 | 6596 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2005 | 4853 | 0.010 |
Why?
|
Biopsy | 1 | 2009 | 6779 | 0.010 |
Why?
|
Glucocorticoids | 1 | 2007 | 2158 | 0.010 |
Why?
|
Cholesterol, LDL | 1 | 2007 | 2392 | 0.010 |
Why?
|
Antigens, CD | 1 | 2007 | 4032 | 0.010 |
Why?
|
Software | 1 | 2011 | 4466 | 0.010 |
Why?
|
Health Status Disparities | 1 | 2008 | 1880 | 0.010 |
Why?
|
Occupational Exposure | 1 | 2006 | 1807 | 0.010 |
Why?
|
Length of Stay | 1 | 2010 | 6490 | 0.010 |
Why?
|
Pilot Projects | 1 | 2009 | 8728 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2013 | 9611 | 0.010 |
Why?
|
Ultrasonography | 1 | 2009 | 5992 | 0.010 |
Why?
|
Public Health | 1 | 2008 | 2681 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2009 | 12430 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2013 | 18330 | 0.010 |
Why?
|
Skin | 1 | 2007 | 4499 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2019 | 15657 | 0.010 |
Why?
|
Boston | 1 | 2006 | 9346 | 0.010 |
Why?
|
Health Status | 1 | 2006 | 4087 | 0.010 |
Why?
|